Halozyme Therapeutics Inc (LTS:0J2O) Stock News, Headlines & Updates
Halozyme Therapeutics Inc Stock News from GuruFocus
- 1
Jun 13, 2024
Insider Sale: Director Matthew Posard Sells Shares of Halozyme Therapeutics Inc (HALO)
GuruFocus Research • 5:00pm
Jun 06, 2024
Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook
PRNewswire • 8:00am
Jun 05, 2024
Halozyme Announces Issuance of New European Patent for ENHANZE® Drug Delivery Platform
PRNewswire • 4:00pm
Jun 04, 2024
Halozyme to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PRNewswire • 4:00pm
May 21, 2024
Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®
PRNewswire • 7:00am
May 08, 2024
Halozyme to Participate in Upcoming Investor Conferences
PRNewswire • 8:00am
Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and Strategic Advances
GuruFocus Research • 1:52am
Q1 2024 Halozyme Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:18pm
May 07, 2024
Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
GuruFocus Research • 3:49pm
Apr 25, 2024
Mahesh Krishnan Elected to Halozyme's Board of Directors
PRNewswire • 4:00pm
Apr 23, 2024
Halozyme to Report First Quarter 2024 Financial and Operating Results
PRNewswire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news